SCHEMBL4772435

SCHEMBL4772435

CC(=O)OCCN1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 12/20 0.54
HTR2A P28223 12/20 0.54
HTR7 P34969 12/20 0.54
HTR6 P50406 12/20 0.54
OPRM1 P35372 2/20 0.52
OPRK1 P41145 2/20 0.52
OPRL1 P41146 2/20 0.52
SLC18A3 Q16572 1/20 0.49
BACE1 P56817 3/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2302359 0.80 HTR7 (0.62) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL31623081 0.78 OPRM1 (0.53) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL8328393 0.78 OPRM1 (0.53) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25317024 0.78 HTR7 (0.62) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL2298743 0.77 OPRM1 (0.63) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL1700315 0.77 OPRM1 (0.58) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL7978260 0.75 OPRK1 (0.49) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25317717 0.75 HTR1A (0.48) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25362520 0.74 OPRM1 (0.56) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25362517 0.74 OPRM1 (0.56) HTR1AHTR2AHTR7HTR6OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890696-A2 NOVEL 3-SPIROCYCLIC INDOLYL DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-02-27 EP disclosed
WO-2006130416-A2 NOVEL 3-SPIROCYCLIC INDOLYL DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-12-07 WO disclosed